Aspiriant 13F: New $1.9M Stake in DFAI

Aspiriant has taken a new position in the Dimensional International Core Equity Market ETF (DFAI) with 46,041 shares, valued at approximately $1.91 million. This move was disclosed in a filing on October 16, 2026, and reflects the fund's interest in companies of various sizes, particularly smaller, more profitable ones.

What Changed in Aspiriant's Position

Aspiriant's filing shows that it opened a new position in DFAI, acquiring 46,041 shares. This significant entry into the fund shows a clear commitment to this investment strategy that focuses on equity securities.

Other Institutional Activity in DFAI

As the fund grows, it will be interesting to see if other investors follow Aspiriant's lead or if they take different approaches.

Dimensional International Core Equity Market ETF Stock Holds Steady

As of October 16, 2026, DFAI traded recently at $41.49, which is below its 50-day moving average of about $42.47, indicating it may present a buying opportunity for some. The ETF is also trading about 4.8% below its 52-week high of $43.59, but remains 16.3% above its 52-week low of $35.68.

Recent Earnings

DFAI has a P/E ratio of 16.81 and a trailing twelve-month revenue growth of 2.43%.

Dividend

DFAI offers a dividend yield of 2.43%, making it attractive for income-focused investors.

Insider Buying and Selling at Dimensional International Core Equity Market ETF

There have been no reported insider trades in DFAI. This may indicate stability in management's view on the fund's future direction.

Analysts Set New Price Targets

No recent analyst ratings or price targets for DFAI have been reported. Any updates from analysts could shed more light on market expectations for this ETF.

About Dimensional International Core Equity Market ETF

The Dimensional International Core Equity Market ETF aims to invest in companies across various sizes, focusing on smaller capitalization firms that offer strong profitability. This strategy aligns with recent investment trends favoring diversified equity exposure in international markets.

Bottom Line

Aspiriant's new position in DFAI could signal a growing interest in international equity markets. As a reminder, 13F filings reflect holdings as of the reporting period and may not represent the fund's current position. Investors should watch for future filings and any upcoming earnings announcements for more insights into the ETF's performance. Keep in mind that 13F filings are backward-looking: they show holdings as of the end of the reporting quarter and may not represent the fund's current position.